Supplemental studies in progress propose that ARV-825 may also be effective in maximizing the response to estrogen deprivation (aromatase inhibition), another element of normal of treatment in ER+ breast cancer. - "Our study disclosed the critical role with the KLF16/MYC regulatory axis in modulating tumor development and chemotherapy sensitivity in https://traudls999fqb2.blogpixi.com/profile